BioCrude Technologies USA, Inc.

EDGAR

Market value is not computed: no listed ticker is recorded for this company.

44 filing records in this dataset, filed from 2016-12-01 to 2026-11-12. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

No Form 3, 4 or 5 for this issuer is in the store. The store has read filings dated 2004-06-14 to 2026-11-20; this is not a statement that none were filed.

Institutional holders (Form 13F)

Trades by members of Congress

See all insider transactions

Latest quarter

Revenue

0 USD

2024 Q3 · USD

Exact inputs and evidence

Operating cash flow

-13.1 thousand USD

2024 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -178603 USD Source
  • Operating Cash Flow: -165467 USD Source

Free cash flow

-13.1 thousand USD

2024 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -178603 USD Source
  • Operating Cash Flow: -165467 USD Source
  • Capital Expenditure: 1239 USD Source
  • Capital Expenditure: 1239 USD Source
Cash and cash equivalents
1.78 thousand USD Source
Exact value

1778 USD

Long-term debt including current maturities
103 thousand USD
Exact inputs and evidence

103125 USD

  • Long-term debt including current maturities: 103125 USD Source
Shares outstanding
50.9 million shares Source
Exact value

50881092 shares

Reported share-count change

0.05% · 26.4 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 50854726 shares · 2025-09-30· Source
  • 50881092 shares · 2026-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Operating cash flow

-133 thousand USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Operating cash flow: -161368 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -83165 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -13372 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -41647 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -13372 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -54948 USD · 2026-01-01 – 2026-09-30 Source
  • Operating cash flow: -41647 USD · 2026-01-01 – 2026-06-30 Source

Capital expenditure

2.55 thousand USD

2024-01-01 – 2024-12-31

Exact inputs and evidence
  • Capital expenditure: -0 USD · 2024-01-01 – 2024-03-31 Source
  • Capital expenditure: 1239 USD · 2024-01-01 – 2024-06-30 Source
  • Capital expenditure: -0 USD · 2024-01-01 – 2024-03-31 Source
  • Capital expenditure: 1239 USD · 2024-01-01 – 2024-09-30 Source
  • Capital expenditure: 1239 USD · 2024-01-01 – 2024-06-30 Source
  • Capital expenditure: 2550 USD · 2024-01-01 – 2024-12-31 Source
  • Capital expenditure: 1239 USD · 2024-01-01 – 2024-09-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2026-11-12.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 10 of 11 periods available· newest 2025-12-31
  • Net income: 9 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 10 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 5 of 11 periods available· newest 2024-12-31
  • Total assets: 10 of 11 periods available· newest 2025-12-31
  • Total liabilities: 10 of 11 periods available· newest 2025-12-31
  • Current assets: 6 of 11 periods available· newest 2025-12-31
  • Current liabilities: 5 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 6 of 11 periods available· newest 2021-12-31
  • Long-term debt including current maturities: 2 of 11 periods available· newest 2022-12-31
  • Shares outstanding: 10 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    +USD 83,314

    Prior period

    −USD 280,756

    –

    Current period

    −USD 197,442

    –

    Exact inputs and evidence

    -197442 − -280756 = 83314 USD

    -280756 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -197442 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 42,360

    Prior period

    −USD 203,728

    –

    Current period

    −USD 161,368

    –

    Exact inputs and evidence

    -161368 − -203728 = 42360 USD

    -203728 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -161368 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2016 2016-01-01 – 2016-12-31
−USD 190,622
Exact value

Exact value: -190622 USD

2016-01-01 – 2016-12-31: -190622 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 158,227
Exact value

Exact value: -158227 USD

2016-01-01 – 2016-12-31: -158227 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2017 2017-01-01 – 2017-12-31
−USD 523,305
Exact value

Exact value: -523305 USD

2017-01-01 – 2017-12-31: -523305 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 84,394
Exact value

Exact value: -84394 USD

2017-01-01 – 2017-12-31: -84394 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2018 2018-01-01 – 2018-12-31
Unavailable Not reported for this period.
−USD 417,321
Exact value

Exact value: -417321 USD

2018-01-01 – 2018-12-31: -417321 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 27,145
Exact value

Exact value: 27145 USD

2018-01-01 – 2018-12-31: 27145 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 444,466
Calculation and evidence

-417321 − 27145 USD

Exact free cash flow: -444466 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 289,627
Exact value

Exact value: -289627 USD

2019-01-01 – 2019-12-31: -289627 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 90,177
Exact value

Exact value: -90177 USD

2019-01-01 – 2019-12-31: -90177 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2020 2020-01-01 – 2020-12-31
−USD 288,485
Exact value

Exact value: -288485 USD

2020-01-01 – 2020-12-31: -288485 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 279,584
Exact value

Exact value: -279584 USD

2020-01-01 – 2020-12-31: -279584 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2021 2021-01-01 – 2021-12-31
−USD 431,455
Exact value

Exact value: -431455 USD

2021-01-01 – 2021-12-31: -431455 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 310,266
Exact value

Exact value: -310266 USD

2021-01-01 – 2021-12-31: -310266 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 5,092
Exact value

Exact value: 5092 USD

2021-01-01 – 2021-12-31: 5092 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 315,358
Calculation and evidence

-310266 − 5092 USD

Exact free cash flow: -315358 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 181,526
Exact value

Exact value: -181526 USD

2022-01-01 – 2022-12-31: -181526 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 158,224
Exact value

Exact value: -158224 USD

2022-01-01 – 2022-12-31: -158224 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1,104
Exact value

Exact value: 1104 USD

2022-01-01 – 2022-12-31: 1104 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 159,328
Calculation and evidence

-158224 − 1104 USD

Exact free cash flow: -159328 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 244,191
Exact value

Exact value: -244191 USD

2023-01-01 – 2023-12-31: -244191 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 164,149
Exact value

Exact value: -164149 USD

2023-01-01 – 2023-12-31: -164149 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 2,240
Exact value

Exact value: 2240 USD

2023-01-01 – 2023-12-31: 2240 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 166,389
Calculation and evidence

-164149 − 2240 USD

Exact free cash flow: -166389 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 280,756
Exact value

Exact value: -280756 USD

2024-01-01 – 2024-12-31: -280756 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 203,728
Exact value

Exact value: -203728 USD

2024-01-01 – 2024-12-31: -203728 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 2,550
Exact value

Exact value: 2550 USD

2024-01-01 – 2024-12-31: 2550 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 206,278
Calculation and evidence

-203728 − 2550 USD

Exact free cash flow: -206278 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−USD 197,442
Exact value

Exact value: -197442 USD

2025-01-01 – 2025-12-31: -197442 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 161,368
Exact value

Exact value: -161368 USD

2025-01-01 – 2025-12-31: -161368 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

44 filings · 1,509 latest values · 1,509 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001690384, 1690384, edgar:1690384

Also known as BIOCRUDE TECHNOLOGIES USA, INC., BioCrude Technologies USA, Inc.